Literature DB >> 3180342

Cell specific differences in O6-methylguanine-DNA methyltransferase activity and removal of O6-methylguanine in rat pulmonary cells.

S A Belinsky1, M E Dolan, C M White, R R Maronpot, A E Pegg, M W Anderson.   

Abstract

Previous studies have demonstrated that cell specificity exists for the alkylation of DNA from lung cells following treatment of rats with the tobacco specific carcinogen 4-(N-methyl-N-nitrosamino)-1-(3-pyridyl)-1-butanone (NNK). The concentration of the promutagenic adduct O6-methylguanine (O6MG) was found to be greatest in Clara cells followed by macrophages, type II cells and alveolar small cells. The purpose of this study was to measure the activity of the repair protein O6-methylguanine-DNA methyltransferase (O6MGMT) and to determine whether differences exist for the removal of O6MG among pulmonary cell types. Constitutive activity of O6MGMT was 2-fold greater in macrophages and type II cells than alveolar small cells and Clara cells. Treatment for 4 days with NNK (10 mg/kg/day) had no effect on O6MGMT activity in macrophages, but decreased activity in alveolar small cells and type II cells by 57 and 84%, respectively. O6MGMT activity was reduced to below limits of detection in Clara cells following treatment with NNK. The effect of NNK on O6MGMT activity was consistent with rates of removal of O6MG in macrophages and Clara cells. The loss of O6MG from DNA of macrophages followed first order kinetics (t1/2 = 48 h) while very little loss of this adduct was observed in Clara cells over an 8 day period following cessation of carcinogen treatment. Even though O6MGMT activity was reduced in alveolar small cells and type II cells, approximately 90% of the O6MG bound to DNA in these cell types was removed within 8 days after treatment was discontinued. The loss of O6MG from pulmonary cells appears to result largely from the removal of this adduct by O6MGMT since rates of cell turnover were very low (0.5-1.5%/day) in the lung and were not affected by treatment with NNK. This study indicates that the activity of O6MGMT and the rate of resynthesis of this repair enzyme differ considerably among pulmonary cells following the methylation of DNA. The high concentration of O6MG in Clara cells and the low rate of repair of this promutagenic adduct may be critical factors in the potent pulmonary carcinogenicity induced by the tobacco specific carcinogen NNK.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3180342     DOI: 10.1093/carcin/9.11.2053

Source DB:  PubMed          Journal:  Carcinogenesis        ISSN: 0143-3334            Impact factor:   4.944


  8 in total

Review 1.  Evolutionary consequences of nonrandom damage and repair of chromatin domains.

Authors:  T Boulikas
Journal:  J Mol Evol       Date:  1992-08       Impact factor: 2.395

Review 2.  Context Matters: Contribution of Specific DNA Adducts to the Genotoxic Properties of the Tobacco-Specific Nitrosamine NNK.

Authors:  Lisa A Peterson
Journal:  Chem Res Toxicol       Date:  2016-12-08       Impact factor: 3.739

3.  Implication of a Chromosome 15q15.2 Locus in Regulating UBR1 and Predisposing Smokers to MGMT Methylation in Lung.

Authors:  Shuguang Leng; Guodong Wu; Leonard B Collins; Cynthia L Thomas; Carmen S Tellez; Andrew R Jauregui; Maria A Picchi; Xiequn Zhang; Daniel E Juri; Dhimant Desai; Shantu G Amin; Richard E Crowell; Christine A Stidley; Yushi Liu; James A Swenberg; Yong Lin; Marc G Wathelet; Frank D Gilliland; Steven A Belinsky
Journal:  Cancer Res       Date:  2015-07-16       Impact factor: 12.701

4.  Dietary Dihydromethysticin Increases Glucuronidation of 4-(Methylnitrosamino)-1-(3-Pyridyl)-1-Butanol in A/J Mice, Potentially Enhancing Its Detoxification.

Authors:  Sreekanth C Narayanapillai; Linda B von Weymarn; Steven G Carmella; Pablo Leitzman; Jordan Paladino; Pramod Upadhyaya; Stephen S Hecht; Sharon E Murphy; Chengguo Xing
Journal:  Drug Metab Dispos       Date:  2016-01-07       Impact factor: 3.922

5.  Dihydromethysticin from kava blocks tobacco carcinogen 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone-induced lung tumorigenesis and differentially reduces DNA damage in A/J mice.

Authors:  Sreekanth C Narayanapillai; Silvia Balbo; Pablo Leitzman; Alex E Grill; Pramod Upadhyaya; Ahmad Ali Shaik; Bo Zhou; M Gerard O'Sullivan; Lisa A Peterson; Junxuan Lu; Stephen S Hecht; Chengguo Xing
Journal:  Carcinogenesis       Date:  2014-07-22       Impact factor: 4.944

6.  Comparative levels of O6-methylguanine, pyridyloxobutyl-, and pyridylhydroxybutyl-DNA adducts in lung and liver of rats treated chronically with the tobacco-specific carcinogen 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone.

Authors:  Pramod Upadhyaya; Bruce R Lindgren; Stephen S Hecht
Journal:  Drug Metab Dispos       Date:  2009-03-26       Impact factor: 3.922

7.  N-7-Alkyl-2'-Deoxyguanosine as surrogate biomarkers for N-nitrosamine exposure in human lung.

Authors:  Natarajan Ganesan; Shunji Kato; Elise D Bowman; Peter G Shields
Journal:  Int J Canc Prev       Date:  2007

Review 8.  The formation and biological significance of N7-guanine adducts.

Authors:  Gunnar Boysen; Brian F Pachkowski; Jun Nakamura; James A Swenberg
Journal:  Mutat Res       Date:  2009-05-22       Impact factor: 2.433

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.